Vol 13, Núm 4

Investigación y desarrollo de vacunas contra el SARS-CoV-2 en tiempos de pandemia

García-Piñero, Alexis.

Texto completo PDF.

Referencias bibliográficas

  1. https://www.who.int/docs/default-source/blue print/20201217-novel-coronavirus_landscape_ covid-19.xlsx.zip?sfvrsn=a5dc3b8d_14&download=true 
  2. Yen-Der Li, Wei-Yu Chi, Jun-Han Su, Louise Ferrall , Chien Fu Hung , T-C Wu. Coronavirus vaccine development:  from SARS and MERS to COVID-19. J Biomed Sci 2020  Dec 20;27(1):104. doi: 10.1186/s12929-020-00695-2  
  3. Mohammad S. Khuroo, Mohammad Khuroo, Mehnaaz S.  Khuroo, Ahmad A. Sofi,and Naira S. Khuroo. COVID-19  Vaccines: A Race Against Time in the Middle of Death  and Devastation! J Clin Exp Hepatol. 2020 Nov-Dec;  10(6): 610–621. doi: 10.1016/j.jceh.2020.06.003 
  4. Subodh Kumar Samrat, Anil M. Tharappel, Zhong  Li, and Hongmin Li. Prospect of SARS-CoV-2 spike development. Virus Res. 2020 Oct 15; 288:  198141.doi: 10.1016/j.virusres.2020.198141
  5. Jee Young Chung, Melissa N. Thone, and Young  Jik Kwona. COVID-19 vaccines: The status and  perspectives in delivery points of view. Adv Drug Deliv  Rev. 2020 Dec 24. doi: 10.1016/j.addr.2020.12.011
  6. Shakti Singh, Rakesh Kumar and Babita Agrawal.  Adenoviral Vector-Based Vaccines and Gene  Therapies:Current Status and Future Prospects.  http://dx.doi.org/10.5772/intechopen.79697}
  7. Changhua Yi, Yongxiang Yi, and Junwei Li. mRNA Vaccines:  Possible Tools to Combat SARS-CoV-2. Virol Sin. 2020  Jun; 35(3): 259–262. doi: 10.1007/s12250-020-00243-0